In Hepa1-6 implanted tumor-bearing model, anti-Spp1 monoclonal antibody (mAb), anti-Cd44 mAb, or anti-Pd-1 mAb alone significantly inhibited the growth of tumors. Here, CD44 is linked to neoplasm.